Marion V Guerin

7PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
Lymph node fine-tuning FcγR signaling boosts anti-PD-1 therapy.

|Jun 10, 2026
Lymph node microenvironment remodeling unlocks local antibody-mediated B cell depletion.

|Feb 28, 2024
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.

Mathilde Ruggiu, Marion V Guérin, Béatrice Corre

|Jul 27, 2022
Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy.

Anaïs Vermare, Marion V Guérin, Elisa Peranzoni

|Nov 26, 2020
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse.

Marion V Guerin, Fabienne Regnier, Maxime Thoreau

|Jan 29, 2020
Preclinical murine tumor models: a structural and functional perspective.

Marion V Guerin, Veronica Finisguerra, Benoit J Van den Eynde

Pageof 2

Frequent Collaborators

3 joint publications

Alain Trautmann

3 joint publications

Fabrice Lemaître

2 joint publications

Nadege Bercovici

2 joint publications

Philippe Bousso